Squamous cell carcinoma of the anus: Another sexually transmitted disease

Swiss Medical Weekly

Volumn 133, Issue 25-26, 2003, Pages 353-359

  Gervaz, Pascal ^a   Allal, Abdelkarim S ^b   Villiger, Peter ^b   Bühler, Léo ^b   Morel, Philippe ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

AIDS; Anal cancer; Chemoradiation; Human papilloma virus; Molecular biology

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CARCINOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CYTOLOGY; DYSPLASIA; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; REVIEW; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL CARCINOMA; SURVIVAL;

EID: 0042362145     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin 2000; 50:7-33.
2. Ryan DP, Compton C, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000; 342:792-800.
3. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994; 8:283-95.
4. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994; 86:1711-6.
5. Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000; 27:390-401.
6. Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986; 58:611-6.
7. Frisch M, Glimelius B, van den Brule AJC, Wohlfart J, Meijer CJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337:1350-8.
8. Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87:61-4.
9. Northfelt DW. Cervical and anal neoplasia and HPV infection in persons with HIV infection. Oncology 1994; 8:32-7.
10. Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991; 338:657-9.
11. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ, et al. High incidence of anal cancer among AIDS patients. Lancet 1994; 343:636-9.
12. Caussy D, Goedert JJ, Palefsky J, et al. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormalities in homosexual men. Int J Cancer 1990; 46:214-9.
13. Palefsky JM, Gonzales J, Greenblatt RM, Ahn DK, Hollander H. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA 1990; 263:2911-6.
14. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281:1822-9.
15. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, et al. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998; 58:3839-44.
16. Chen T, Pecaro G, Defendi V. Genetic analysis of in vitro progression of human papillomavirus transfected human cervical cells. Cancer Res 1993; 53:1167-71.
17. Critchlow CW, Hawes SE, Kuypers J, Goldbaum G, Holmes K, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 1998; 12:1177-84.
18. Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol 1997; 50:625-34.
19. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361-7.
20. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Jay N, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Def Syndr Hum Retrovirol 1998; 17:320-6.
21. Rader JS, Kamarasova T, Huettner PC, Li L, et al. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene 1996; 13:2737-41.
22. Muleris M, Salmon RJ, Girodet J, Zafrani B, Dutrillaux B. Recurrent deletions of chromosomes 11q and 3p in anal canal carcinoma. Int J Cancer 1987; 39:595-8.
23. Heselmeyer K, du Manoir S, Blegen H, Friberg B, Svensson C, et al. A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas. Br J Cancer 1997; 76:1271-8.
24. Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1999; 45:309-14.
25. Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, et al. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer 1999; 85:1226-33.
26. Gervaz P, Efron J, Alonso Poza A, Chun SW, Pham TT, et al. Loss of heterozygosity and HIV infection in patients with anal squamous-cell carcinoma. Dis Colon Rectum 2001; 44:1503-8.
27. Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ. Anal canal and perianal epidermoid cancers. J Am Coll Surg 1997; 185:494-505.
28. Corman ML. Malignant tumors of the anal canal. In: Colon & Rectal Surgery, 4th edition Lippincott-Raven Pub. 1998: pp. 863-883.
29. Ryan DP, Mayer RJ. Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol 2000; 12:345-52.
30. Savoca PE, Wong WD. Anal carcinoma: anatomy, staging and prognostic variables. In: Cohen AM, Winaver SJ, eds. Cancer of the Colon, Rectum and Anus. McGraw-Hill Publ. (1st Ed) 1995: pp 1013-20.
31. Harmer MH, ed. TNM classification of malignant tumors, 3rd Ed. Geneva, Switzerland, 1978: pp. 77-81.
32. Cummings BJ. Anal cancer: radiation, with and without chemotherapy. In: Cohen AM, Winawer SJ, eds. Cancer of the Colon, Rectum and Anus. McGraw-Hill Publ. (1st Ed) 1995: pp 1025-42.
33. Tarantino D, Bernstein MA. Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal. Dis Colon Rectum 2002; 45:16-22.
34. Magdeburg B, Fried M, Meyenberger C. Endoscopic ultrasonography in the diagnosis, staging and follow-up of anal carcinomas. Endoscopy 1999;31:359-564.
35. Bartram CI, Burnett SJD. In Atlas of anal endosonography (1st Ed). Butterworth-Heinemann, Oxford (1991).
36. Hill J, Meadows H, Haboubi N, Talbot IC, Northover JMA. Pathological staging of epidermoid anal carcinoma for the new era. Colorectal Disease 2003; 5:206-13.
37. Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT, Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum 1981; 24:73-5.
38. Longo WE, Vernava AM III, Wade TP, Coplin MA, et al. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg 1994; 220:40-9.
39. Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002; 89:1425-9.
40. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti MC. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999; 86:405-9.
41. Greenall MJ, Quan SHQ, Stearns MW, et al. Epidermoid cancer of the anal margin. Am J Surg 1985; 149:95-101.
42. Northover JMA, UKCCCR anal cancer trial working party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996; 348:1049-54.
43. Bartelink H, Roelofsen F, Eschewege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomised trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15:2040-9.
44. Vordermark D, Sailer M, Flentje M, Thiede A, Kolbl O. Impaired sphincter function and good quality of life in anal carcinoma patients after radiotherapy: a paradox? Front Radiat Ther Oncol 2002; 37:132-9.
45. Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998; 41:488-93.
46. Cleator S, Fife K, Nelson M, Gazzard B, Phillips R, Bower M. Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer 2000; 36:754-8.
47. Vatra B, Sobhani I, Aparicio T, Girard PM, Puy Montbrun TD, et al. Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis. Gastroenterol Clin Biol 2002; 26:147-9.
48. Place RJ, Gregorcyk SG, Huber PJ, Simmang CL. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001; 44:506-12.
49. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281: 1822-9.
50. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. J Acquir Immune Defic Syndr 1999; 21:33-41.
51. Palefsky JM, Holly EA, Ralston ML, et al. High incidence of anal high grade squamous intraepithelial lesions among HIV positive and HIV negative homosexual and bisexual men. AIDS 1998; 12:495-503.
52. Palefsky JM, Holly EA, Ralston ML, et al. The effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal HPV infection. J Acquir Immune Defic Syndr 2001; 28:422-8.